Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina

The source of the below information is the publicly available website ClinicalTrials.gov. It has been summarised and edited into simpler language.

The below information is taken directly from the publicly available website ClinicalTrials.gov within a week of any updates, and has not been edited.

Results Disclaimer